Calamos Advisors LLC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAF5. A total of 48 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Calamos Advisors LLC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2020$9,510,000
+4.6%
10,000,0000.0%0.06%
-6.8%
Q3 2020$9,091,000
+4.1%
10,000,0000.0%0.06%
-4.8%
Q2 2020$8,730,000
-29.7%
10,000,000
-33.3%
0.06%
-36.1%
Q1 2020$12,422,000
-4.7%
15,000,0000.0%0.10%
+51.6%
Q4 2019$13,033,000
+4.1%
15,000,0000.0%0.06%
-5.9%
Q3 2019$12,515,000
-3.3%
15,000,0000.0%0.07%
-5.6%
Q2 2019$12,940,00015,000,0000.07%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
CANYON CAPITAL ADVISORS LLC 40,000,000$38,988,0001.44%
Penn Mutual Asset Management, LLC 1,204,000$1,174,0001.36%
TFG Asset Management GP Ltd 21,600,000$21,148,0000.96%
PALISADE CAPITAL MANAGEMENT, LP 10,006,000$9,832,0000.23%
TENOR CAPITAL MANAGEMENT Co., L.P. 11,645,000$11,431,0000.22%
OAKTREE CAPITAL MANAGEMENT LP 20,353,000$19,882,0000.21%
Wellesley Asset Management 2,304$2,245,0000.15%
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP 10,000,000$9,719,0000.12%
SSI INVESTMENT MANAGEMENT LLC 2,000,000$1,942,0000.11%
Cutler Capital Management, LLC 300,000$291,0000.10%
View complete list of LIGAND PHARMACEUTICALS INC shareholders